
CareDx to Present AlloHeme Data at 2025 Tandem Meetings on Early Relapse Detection
CareDx to Present AlloHeme Data at 2025 Tandem Meetings on Early Relapse Detection CareDx, Inc. (Nasdaq: CDNA), a leader in precision medicine focused on transplant patients and caregivers, today announced the presentation of new AlloHeme data at the 2025 Tandem…











